Athira Pharma, Inc.Athira Pharma, Inc.Athira Pharma, Inc.

Athira Pharma, Inc.

No trades
See on Supercharts

Price target

8.100.00 0.00%
The 5 analysts offering 1 year price forecasts for ATHA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ATHA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ATHA EPS for the last quarter is −0.71 USD despite the estimation of −0.84 USD. In the next quarter EPS is expected to reach −0.80 USD. Track more of Athira Pharma, Inc. financials and stay on top of what is up with the company.
According to analysts, ATHA price target is 8.10 USD with a max estimate of 19.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ATHA news and stock market news.
We've gathered opinions of 5 analysts rating ATHA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.